Download PDF Introduction This week Merck & Co. announced one of the biggest healthcare deals disclosed so far in 2023. The US drug maker reached an agreement with Prometheus Biosciences to acquire the company in an all-cash transaction that values Prometheus at $10.8bn, a 75% premium to its market cap Read more…
Download PDF Merck & Co. (NYSE: MRK) Market Cap as of 8th October 2021 – $204.10bn Acceleron Pharma, Inc. (NASDAQ: XLRN) Market Cap as of 8th October 2021 – $10.68bn Introduction On Thursday 30th September, Merck & Co.’s acquisition of Acceleron Pharma for a total consideration of about $11.5bn was announced. Merck has agreed Read more…
Download PDF Introduction The pharmaceuticals sector has been the center of attention lately for the successful vaccines trial that finally gave some hope of recovery, even though it wasn’t without controversies. However, a lot more has been going on in the industry that might change the reputation that the industry Read more…
Novartis AG (SIX: NOVN) – market cap as of 20/04/2018: CHF204.12bn AveXis Inc (NASDAQ: AVXS) – market cap as of 20/04/2018: $7.62bn Introduction On April 9, Novartis submitted an offer to acquire all the shares of the American gene therapy group AveXis. The Swiss drugmaker offered an 88% premium adding Read more…
Allergan (AGN) – Market cap as of 07/10/2016: $94.6bn About Allergan Allergan plc is a diversified global pharmaceutical company headquartered in Dublin, Ireland. It is considered to be a leader in “growth pharma”, after its newfound focus on branded pharmaceuticals. Since 2007 Allergan has made a number of acquisitions to Read more…
Teva Pharmaceutical Industries ; Market Cap (as of 25/04/2015): $62,67bn Mylan Pharmaceuticals ; Market Cap (as of 25/04/2015): $36,06bn Introduction In the healthcare industry, the saying “eat or be eaten” no longer applies. Instead, the adage of “make a bid or wait for an offer” would be more appropriate Read more…
Endo International Plc; Market Cap (as of 13/03/2015): $15.4bn Salix Pharmaceuticals Ltd; Market Cap (as of 13/03/2015): $10.8bn Valeant Pharmaceuticals Intl, Inc.; Market Cap (as of 13/03/2015): $63.9bn The pharmaceutical sector has turned into a war-zone again with of the bidding war between two aggressive dealmakers and two ex-colleagues: Mr. Read more…
Actavis Plc, Market Cap (as of 21/02/14): $38.35bn Forest Laboratories Inc, Market Cap (as of 21/02/14): $26.36bn On February 18th, 2014 the Dublin-based generic drug maker, Actavis PLC, announced an acquisition of the New York-based specialty drug maker, Forest Laboratories Inc, in a $25bn cash-and-equity deal. If successfully completed, the Read more…
Merck KGaA Market Cap (as of 06/12/13): €27.84bn AZ Electronic Materials SA Market Cap (as of 06/12/13): €1.79bn On December 5, 2013 the Darmstadt-based German drug and chemicals company, Merck KGaA, announced an agreement with the Board of Directors of AZ Electronic Materials SA (AZ) regarding a recommended $2.57bn all-cash Read more…